New diagnostic applications of prostate-specific antigen

British Journal of Urology

Volumn 79, Issue SUPPL. 1, 1997, Pages 87-91

  Diamandis, E P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN SPECIFICITY; BLOOD LEVEL; CONFERENCE PAPER; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

FEMALE; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES; SENSITIVITY AND SPECIFICITY;

EID: 0031401517     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410x.1997.tb00807.x     Document Type: Article

References (53)

1. Kara M, Inorre T, Fukuyama T. Some physico-chemical characteristics of gamma-seminoprotein, an antigenic component specific for human seminal plasma. Jap J Legal Med 1971; 25: 322-6
2. Wang MC, Valenzuele LA, Murphy GP, Chu TM. Purification of human prostate specific antigen. Invest Urol 1979; 17: 159-63
3. Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM. A prostate antigen in sera of prostatic cancer patients. Cancer Res 1980; 40: 2428-32
4. Riegman PHJ, Klaassen P, Van der Korput JAGM, Romijn JC, Trapman J. Molecular cloning and characterisation of novel prostate antigen cDNAs. Biochem Biophys Res Commun 1988; 155: 181-8
5. Schedlich LJ, Bennetts BH, Morris BJ. Primary structure of a human glandular kallikrein gene. DNA 1987; 6: 429-37
6. Clements JA. The glandular kallikrein family of enzymes: tissue-specific expresion and hormonal regulation. Endocrine Rev 1989; 10: 393-419
7. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907-23
8. Lilja H. A kallikrein-like serine protease in prostatic fluid leaves the predominant seminal vesicle protein. J Clin Invest 1985: 76: 1899-903
9. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222-6
10. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990; 194: 755-63
11. 1-antichymotrypsin. Clin Chem 1991; 37: 1618-25
12. 1-antichymotrypsin complex. Clin Chem 1995; 41: 1480-8
13. Yu H, Diamandis EP. Ultrasensitive time-resolved immunofluorometric assay of prostate specific antigen in serum and preliminary clinical studies. Clin Chem 1993; 39: 2108-14
14. Papotti M, Paties C. Peveri V. Moscuzza L, Bussolati G. Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors. Bas Appl Histochem 1989; 33: 25-9
15. McLachlin SM, Srigley JR. Prostatic tissue in mature cystic teratomas of the ovary. Am J Surg Pathol 1992; 16: 780-4
16. Pummer K, Wirnsberger G, Purstner P. Stettner H. Wondshneider G. False positive prostate specific antigen values in the sera of women with renal cell carcinoma. J Urol 1992: 148:21-3
17. Van Krieken JH. Prostate marker immunoreactivity in salivary gland neoplasms. Am J Surg Pathol 1993; 17: 410-14
18. James GK, Pudek M, Berean KW. Diamandis EP, Archibald BL. Salivary duct carcinoma secreting prostate specific antigen. Am J Clin Pathol 1996: 106, 242-7
19. Kamoshida S. Tsutsumi Y. Extraprostatic localisation of prostate acid phosphatase and prostate specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 1990; 21: 1108-11
20. Frazer HA, Humphrey PA. Burchette JL, Paulson DF. Inununoreactive prostatic specific antigen in male periurethral glands. J Urol 1992; 147: 246-8
21. Iwakiri J, Grandbois K, Wehner N, Graves HCB, Stanley T. An analysis of urinary prostatic specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands. J Urol 1993; 149: 783-6
22. Wernert N, Albrech M, Sesterhenn J et al. The 'female prostate'. Location, morphology, immunohistochemical characteristics and significance. Bur Urol 1992; 22: 64-9
23. Yu H, Diamandis EP. Measurement of serum prostate specific antigen levels in females and in prostatectomised males with an ultrasensitive immunoassay technique. J Urol 1994; 153: 1004-8
24. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994; 32: 291-300
25. Yu H, Diamandis EP, Sutherland DJA. Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994; 27: 75-9
26. Monne M. Croce CM, Yu H, Diamandis EP. Molecular characterisation of prostate specific antigen mRNA expressed in breast tumors. Cancer Res 1994; 54: 6344-7
27. Yu H, Diamandis EP, Levesque MA, Sismondi P, Zola P, Katsaros D. Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary. J Clin Lab Anal 1994; 8: 251-3
28. Yu H, Giai M, Diamandis EP et al. Prostate specific antigen is a new favourable prognostic indicator for women with breast cancer. Cancer Res 1995; 55: 2104-10
29. Yu H, Diamandis EP, Zarghami N, Grass L. Induction of prostate specific antigen production by steroids and tamox-ifen in breast cancer cell lines. Breast Cancer Res Treat 1994; 32: 301-10
30. Beato M. Gene regulation by steroid hormones. Cell 1989; 56: 335-44
31. Clements A, Mukhtar A. Glandular kallikreins and prostate specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 1994; 78: 1536-9
32. Yu H, Diamandis EP, Monne M, Croce CM. Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 1995; 270: 6615-18
33. Yu H, Diamandis EP. Prostate specific antigen in milk of lactating women. Clin Chem 1994; 41: 54-60
34. Diamandis EP, Yu H. Lopez-Otin C. Prostate specific antigen - A new constituent of breast cyst fluid. Breast Cancer Res Treat 1996; 38: 259-64
35. Yu H, Diamandis EP. Prostate specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995: 41: 204-10
36. Levesque M. Yu H. D'Costa M, Diamandis EP. Prostate specific antigen expression by various tumors. J Clin Lab Anal 1995; 9: 123-8
37. Levesque M. Yu H, D'Costa M, Tadross L. Diamandis EP. Immunoreactive prostate specific antigen in lung tumors. J Clin Lab Anal 1995; 9: 375-9
38. Watt KWK. Lee PJ. M'Timkulu T. Chan WP, Loor R. Human prostate specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sei USA 1986: 83: 3166-70
39. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate specific antigen (PSA) is an insulinlike growth factor binding protein-3 protease found in seminal plasma. J Clin Endoc Metab 1992; 75: 1046-53
40. Kanety H, Madjar Y, Dagan Y et al. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate specific antigen. J Clin Endoc Metab 1993; 77: 229-33
41. Killian CS, Corral DA, Kawinski E, Constantine RI. Mitogenic response of osteoblast cells to prostate specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 1993; 192: 940-7
42. Espana F, Gilabert J, Estelles A. Romeu A. Asnar J. Cabo A. Functionally active protein C inhibitorJplasminogen activator inhibitor-3 (PCIJPAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991; 64: 309-20
43. Fichtner J, Graves HCB. Thatcher K, Yemoto C, Shortliffe LMD. Prostate specific antigen releases a kinin-like sub-stance on proteolysis of seminal vesicle fluid that stimulates smooth muscle contraction. J Vrol 1996; 155: 738-42
44. Giai M. Yu H, Roagna R et al. Prostate specific antigen in serum of women with breast cancer. Br J Cancer 1995; 72: 728-31
45. Melegos D. Diamandis EP. Diagnostic value of molecular forms of prostate specific antigen for female breast cancer. Clin Biochem 1996; 29: 193-200
46. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultrasensitive detection of prostate specific antigen by a new time resolved immunofluorometric assay and the IMMULITE immunochemiluminescent third generation assay: potential applications in prostate and breast cancers. Clin Chem 1996; 42: 675-84
47. Yu H. Diamandis EP. Prestigiacomo AF. Stamey TA. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor doubling time after radical prostatectomy. Clin Chem 1995; 41: 430-4
48. Randell EW, Yu H. Diamandis EP. Prestigiacomo AF. Stamey T. Early detection of prostate cancer relapse in post-radical prostatectomy patients using the IMMUL1TE third generation prostate specifie antigen assay. Can J. Oncol 1997; in press
49. Galvan B, Christopoulos TK, Diamandis EP. Detection of prostate specific antigen mRNA by reverse-transcription polymerase chain reaction and time-resolved fluorometry. Clin Chem 1995; 41: 1705-9
50. Diamandis EP. Yu H. Prostate cancer, prostate specific antigen and the polymerase chain reaction. Clin Chem 1995:41: 177-9
51. Deguchi T. Doi T. Ehara H et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993; 53: 5350-4
52. Katz AE. Olsson CA, Raffo AJ et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994; 43: 765-75
53. Jaakkola S, Vornanen T, Leinone J. Rannikko S. Stenman U-H. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate specific antigen. Clin Chem 1995; 41: 182-6